Acer Therapeutics Inc (NASDAQ:ACER)

18.75
Delayed Data
As of Apr 20
 -0.19 / -1.00%
Today’s Change
5.70
Today|||52-Week Range
22.63
+35.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-15.1M-12.0M-8.0M-14.2M
 
 
 
 
 
Depreciation387.8K351.4K238.1K4.0K
 
 
 
 
 
Total Other Cash Flow1.3M915.1K1.8M665.1K
 
 
 
 
 
Funds From Operations-13.4M-10.8M-6.0M-13.5M
 
 
 
 
 
Funds From/For Other Operating Expenses797.0K-241.1K3.2M569.9K
 
 
 
 
 
Net Cash Flow - Operating Activities-14.2M-10.5M-9.2M-14.1M
 
 
 
 
 
 
InvestingCapital Expenditures-190.9K-92.3K-1.2K-62.8K
 
 
 
 
 
Fixed Asset Disposal------1.0M
 
 
Net Cash Flow Investing-190.9K-92.3K-1.2K967.3K
 
 
 
 
 
 
FinancingShort Term Borrowings0.00---186.7K0.00
 
 
Long Term Borrowings0.000.00-82.8K5.4M
 
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale648.2K13.3M334.9K21.5M
 
 
 
 
 
Common Preferred Redeemed0.00-5.0K0.000.00
 
 
Common Dividends0.000.00--0.00--
Cash Dividends Paid - Total0.000.00--0.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing648.2K13.3M65.4K26.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-13.7M2.7M-9.1M13.8M